The Therapeutic Potential of Milk Extracellular Vesicles on Colorectal Cancer

Manal A Babaker1,2, Fadwa A Aljoud3, Faris Alkhilaiwi3,4

  • 1Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia.

Insights

Milk extracellular vesicles (EVs) show promise as a targeted therapy for colorectal cancer, offering a safer alternative to traditional chemotherapy by suppressing tumor cells with fewer side effects.

Area of Science:

  • Oncology
  • Biotechnology
  • Nanomedicine

Background:

  • Colorectal cancer is a leading cause of cancer death globally.
  • Current chemotherapies lack selectivity, harming healthy cells and causing severe side effects.
  • Targeted therapies are crucial for improving cancer treatment efficacy and safety.

Purpose of the Study:

  • To review the biogenesis, isolation, and characterization of milk-derived extracellular vesicles (EVs).
  • To explore the therapeutic potential of milk EVs, particularly in the context of colorectal cancer.
  • To highlight milk EVs as a natural and selective anti-cancer agent.

Main Methods:

  • Literature review on milk EV research.
  • Analysis of studies detailing EV biogenesis and isolation techniques.
  • Examination of research on the anti-tumor effects of milk EVs.

Main Results:

  • Milk EVs from various sources, including camels and cows, demonstrate significant tumor-suppressive properties.
  • These EVs can be isolated and characterized using established methods.
  • The molecular composition of milk EVs contributes to their targeted therapeutic effects.

Conclusions:

  • Milk-derived EVs represent a promising natural product for developing targeted colorectal cancer therapies.
  • Their selective action against tumor cells offers a potential advantage over conventional chemotherapy.
  • Further research into milk EVs could lead to more effective and safer cancer treatments.